Clinical Trial Update: Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis. [NA]

View source ↗

Summary

A clinical trial evaluating midodrine for refractory or recurrent ascites in children with cirrhosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis

Drugs mentioned

• Midodrine (Midodrine)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Refractory Ascites in Children With Cirrhosis | NA | Status: WITHDRAWN